The Charcot Foot in Diabetes

Lee C. Rogers(Valley Presbyterian Hospital), Robert G. Frykberg(Carl T. Hayden Veterans Affairs Medical Center), David G. Armstrong(University of Arizona), Andrew J.M. Boulton(University of Manchester), Michael Edmonds(King's College Hospital), Georges Ha Van(Sorbonne Université), Agnès Hartemann(Sorbonne Université), Frances L. Game(Nottingham University Hospitals NHS Trust), William Jeffcoate(Nottingham University Hospitals NHS Trust), Alexandra Jirkovská(Institute of Clinical and Experimental Medicine), Edward B. Jude(University of Manchester), Stephan Morbach(Marienkrankenhaus Hamburg), William B. Morrison(Thomas Jefferson University Hospital), Michael S. Pinzur(Loyola Medicine), Dario Pitocco(Agostino Gemelli University Polyclinic), Lee Sanders(Veterans Health Administration), Dane K. Wukich(University of Pittsburgh Medical Center), Luigi Uccioli(University of Rome Tor Vergata)
Diabetes Care
August 19, 2011
Cited by 557Open Access
Full Text

Abstract

The diabetic Charcot foot syndrome is a serious and potentially limb-threatening lower-extremity complication of diabetes. First described in 1883, this enigmatic condition continues to challenge even the most experienced practitioners. Now considered an inflammatory syndrome, the diabetic Charcot foot is characterized by varying degrees of bone and joint disorganization secondary to underlying neuropathy, trauma, and perturbations of bone metabolism. An international task force of experts was convened by the American Diabetes Association and the American Podiatric Medical Association in January 2011 to summarize available evidence on the pathophysiology, natural history, presentations, and treatment recommendations for this entity.


Related Papers

No related papers found

Powered by citation graph analysis